Table I.
Summary of mAb reactivity with α2β1 integrin variants. CHO L761h cells were transfected with α21-1129-Fc (FL), α21-806-Fc (TR) or α21-806[I332G] (TRα2[I332G]), and β11-708 (FL), wild-type β11-455 (TR) or mutated β11-455. Recombinant receptors were captured from cell culture supernatants with goat anti-human Fc antibody onto microtiter plates and were analysed for reactivity with 5μg/ml anti-α2 mAbs (JA218, 12F1, P1E6 or Gi9), or anti-β1 mAbs (12G10, TS2/16, 8E3, 4B4, 15/7 or HUTS-4) by ELISA. Results are expressed as a percentage of wild type full-length or truncated α2β1-Fc binding, normalised to the binding of anti-α2 JA128 mAb. Results shown are from one experiment, representative of at least three separate experiments.
| A | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| JA218 | 12F1 | P1E6 | Gi9 | 12G10 | TS2/16 | 8E3 | 4B4 | 15/7 | HUTS4 | |
| FL α2β1 | 107.96 | 53.39 | 109.63 | 77.19 | 115.89 | 116.97 | 57.16 | 50.53 | 83.18 | 86.42 |
| TRα2β1 | 100.00 | 54.25 | 100.30 | 67.90 | 101.05 | 108.20 | 55.80 | 50.25 | 45.10 | 65.25 |
| TRα2β1[D130A] | 89.21 | 43.18 | 89.43 | 51.16 | 97.86 | 98.17 | 52.41 | 42.28 | 55.53 | 73.64 |
| TRα2β1[D137A] | 103.10 | 54.65 | 128.62 | 66.71 | 101.51 | 110.32 | 61.81 | 49.44 | 24.02 | 51.66 |
| TRα2β1[D138A] | 100.73 | 57.87 | 112.22 | 71.67 | 98.21 | 107.11 | 60.19 | 65.48 | 2.42 | 24.88 |
| TRα2β1[D226A] | 95.77 | 56.08 | 101.76 | 69.63 | 103.48 | 98.55 | 62.73 | 53.35 | 55.26 | 75.04 |
| TRα2β1[E169A] | 98.92 | 59.35 | 106.93 | 64.99 | 109.41 | 110.94 | 58.86 | 64.30 | 60.34 | 91.35 |
| TRα2β1[E169D] | 99.18 | 56.33 | 101.41 | 67.49 | 103.59 | 109.94 | 49.39 | 51.37 | 71.65 | 88.86 |
| B | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| JA218 | 12F1 | P1E6 | Gi9 | 12G10 | TS2/16 | 8E3 | 4B4 | 15/7 | HUTS4 | |
| TRα2β1 | 100.00 | 83.15 | 102.00 | 88.75 | 68.30 | 64.65 | 63.20 | 52.55 | 93.15 | 81.90 |
| TRα2[I332G] β1 | 91.72 | 91.72 | 97.87 | 92.32 | 77.09 | 72.37 | 67.74 | 66.82 | 91.77 | 85.62 |
| TRα2[I332G] β1[D130A] | 93.82 | 83.17 | 96.49 | 84.44 | 63.70 | 64.88 | 71.87 | 66.42 | 90.21 | 85.80 |
| TRα2[I332G] β1[D137A] | 130.62 | 96.40 | 97.31 | 89.80 | 75.04 | 77.79 | 100.19 | 77.98 | 88.11 | 83.53 |
| TRα2[I332G] β1[D138A] | 108.93 | 88.83 | 88.50 | 85.78 | 76.79 | 82.95 | 85.29 | 80.93 | 88.99 | 85.13 |
| TRα2[I332G] β1[D226A] | 112.55 | 87.56 | 90.83 | 93.59 | 80.81 | 84.75 | 109.85 | 89.59 | 94.04 | 93.92 |
| TRα2[I332G] β1[E169A] | 96.69 | 93.06 | 98.29 | 95.09 | 83.59 | 79.91 | 93.11 | 85.96 | 94.37 | 94.37 |
| TRα2[I332G] β1[E169D] | 118.06 | 109.45 | 92.50 | 112.63 | 84.06 | 83.41 | 108.62 | 95.99 | 105.67 | 100.06 |